Showing results (171-180 of 219) with videos related to

Sort By:
Pageof 22
Drugs in R&D|December 17, 2020
Safety and Antitumor Activity of Repeated ASP3026 Administration in Japanese Patients with Solid Tumors: A Phase I StudyAkira Ono, Haruyasu Murakami, Takashi Seto, et al.
Investigational New Drugs|August 6, 2022
Phase I study of envafolimab (KN035), a novel subcutaneous single-domain anti-PD-L1 monoclonal antibody, in Japanese patients with advanced solid tumorsToshio Shimizu, Takako Eguchi Nakajima, Noboru Yamamoto, et al.
Cancer Chemotherapy and Pharmacology|October 26, 2022
A feasibility study of lenvatinib plus pembrolizumab in Japanese patients with advanced solid tumorsShigehisa Kitano, Yutaka Fujiwara, Toshio Shimizu, et al.
Investigational New Drugs|August 12, 2015
A phase I/Ib study of trametinib (GSK1120212) alone and in combination with gemcitabine in Japanese patients with advanced solid tumorsAkiyoshi Kasuga, Kazuhiko Nakagawa, Fumio Nagashima, et al.
Annals of Surgical Oncology|December 6, 2006
Influence of overweight on surgical complications for gastric cancer: results from a randomized control trial comparing D2 and extended para-aortic D3 lymphadenectomy (JCOG9501)Toshimasa Tsujinaka, Mitsuru Sasako, Seiichiro Yamamoto, et al.
Investigational New Drugs|November 4, 2022
Oral formulation of bendamustine hydrochloride for patients with advanced solid tumors; a phase 1 studyToshio Shimizu, Kazuhiko Nakagawa, Hidetoshi Hayashi, et al.
Cancer Medicine|April 23, 2024
PD-1 inhibition with retifanlimab and/or arginase inhibition with INCB001158 in Japanese patients with solid tumors: A phase I studyYasutoshi Kuboki, Takafumi Koyama, Nobuaki Matsubara, et al.
Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|December 30, 2011
Differences in excitability between median and superficial radial sensory axonsYumi Fujimaki, Kazuaki Kanai, Sonoko Misawa, et al.
Investigational New Drugs|June 22, 2020
The safety and tolerability of epacadostat alone and in combination with pembrolizumab in patients with advanced solid tumors: results from a first-in-Japanese phase I study (KEYNOTE-434)Toshihiko Doi, Yutaka Fujiwara, Kohei Shitara, et al.
NPJ Precision Oncology|July 17, 2021
Comprehensive functional evaluation of variants of fibroblast growth factor receptor genes in cancerIkuko Takeda Nakamura, Shinji Kohsaka, Masachika Ikegami, et al.
Pageof 22